The role of suppressor T cells in regulation of immune responses

被引:147
作者
McHugh, RS [1 ]
Shevach, EM [1 ]
机构
[1] NIAID, Cellular Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
CD4(+) CD25(+) T cells; immunoregulation; tolerance; autoimmunity; tumor immunity; chronic infection; allergy; immunotherapy;
D O I
10.1067/mai.2002.129339
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Suppressor T cells play important roles in the regulation of immune responses and the mediation of dominant immunologic tolerance. Studies of suppressor T-cell function have been hampered until their recent identification as a minor fraction (approximately 10%) of CD4(+) T cells that coexpress CD25. CD4(+)CD25(+) T cells have been shown to play a critical role in the prevention of organ-specific autoimmunity and allograft rejection. Because tumor antigens are self-antigens, it is not surprising that CD4(+)CD25(+) T cells also inhibit the induction of tumor immunity. The spectrum of activity of CD4(+)CD25(+) cells extends to non-self-antigens, including infectious agents. Indeed, T cell-mediated suppression might be responsible for the low level of chronic infection seen with many pathogens. Interestingly, however, this persistent level of infection might be beneficial to the host and needed for maintenance of immunologic memory. Although CD4(+)CD25(+) T cells are capable of inhibiting T(H)2 responses, their role in the suppression of allergic responses has not been firmly established. Depending on the desired immune response, enhancement or restraint of suppressor T-cell function might be required. Therefore immunologic or pharmacologic manipulation of regulatory T-cell populations represents an important future approach to immunotherapy of a wide range of immune responses.
引用
收藏
页码:693 / 702
页数:10
相关论文
共 80 条
[1]  
Aranda R, 1997, J IMMUNOL, V158, P3464
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]  
AWWAD M, 1989, CANCER RES, V49, P1649
[4]  
AWWAD M, 1988, CANCER IMMUNOL IMMUN, V26, P55
[5]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[6]  
BELKAID Y, 2002, IN PRESS NATURE
[7]  
BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69
[8]   The challenge of viral reservoirs in HIV-1 infection [J].
Blankson, JN ;
Persaud, D ;
Siliciano, RF .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :557-593
[9]   Invasion, control and persistence of Leishmania parasites [J].
Bogdan, C ;
Gessner, A ;
Solbach, W ;
Rollinghoff, M .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :517-525
[10]  
BURSUKER I, 1985, CANCER IMMUNOL IMMUN, V19, P215